MarketScreener Homepage > Equities > NASDAQ OMX COPENHAGEN > Coloplast A/S COLO B DK0060448595

Report

Real-time Estimate CHI-X - 12/02 05:48:55 am
916.8	DKK		+0.57%

11/10

COLOPLAST A/S : - Announcement no. 13/2020 - Notice of Annual General Meeting

11/05

COLOPLAST A/S : - Trading in Coloplast shares by board members, executives or associated persons

11/04

COLOPLAST A/S : Group - delivers solid full year results despite the COVID-19 pandemic and expects 7-8% organic growth and 31-32% EBIT margin for 2020/21

Summary

Quotes 5-day view Delayed Quote.

Delayed Nasdaq Omx Copenhagen

11/26/2020	11/27/2020	11/30/2020	12/01/2020	12/02/2020	Date
905(c)	929.8(c)	931.6(c)	911.6(c)	919.2	Last
251 790	283 544	1 029 691	329 740	76 032	Volume
+0.71%	+2.74%	+0.19%	-2.15%	+0.83%	Change

More quotes

Financials

Sales 2021	19 573 M 3 178 M 3 178 M
Net income 2021	4 735 M 769 M 769 M
Net Debt 2021	1 318 M 214 M 214 M
P/E ratio 2021	41,0x
Yield 2021	2,07%

Sales 2022	21 170 M 3 438 M 3 438 M
Net income 2022	5 168 M 839 M 839 M
Net Debt 2022	1 209 M 196 M 196 M
P/E ratio 2022	37,6x
Yield 2022	2,29%

Capitalization	194 B 31 361 M 31 482 M
EV / Sales 2021	9,97x
EV / Sales 2022	9,22x
Nbr of Employees	12 427
Free-Float	57,3%

More Financials

Company

Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (49.1%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (39.9%): bags and equipment used following intestinal operations; - wound care and skincare products (13%): wound dressings, bandages, creams and...

Sector

Medical Equipment, Supplies & Distribution

Calendar

12/01

Presentation

More about the company

Notations Surperformance© of Coloplast A/S

Trading Rating :

Investor Rating :

More Ratings

All news about COLOPLAST A/S

11/10	COLOPLAST A/S : - Announcement no. 13/2020 - Notice of Annual General Meeting	AQ
11/05	COLOPLAST A/S : - Trading in Coloplast shares by board members, executives or as..	AQ
11/04	COLOPLAST A/S : Group - delivers solid full year results despite the COVID-19 pa..	AQ
11/04	COLOPLAST A/S : acquires Nine Continents Medical, Inc.	AQ
11/03	GLOBAL MARKETS LIVE: Ant Group’s IPO postponed; Deutsche Bank wants to get ri..
11/03	COLOPLAST A/S : Buys Nine Continents Medical for Initial $145 Million	DJ
11/03	COLOPLAST A/S : - Announcement no. 12/2020 - Sustainability Report 2019/20	AQ
11/03	COLOPLAST A/S : - Announcement no. 11/2020 – Annual Report 2019/20 & Remun..	AQ
11/03	COLOPLAST A/S : acquires Nine Continents Medical, Inc.	AQ
11/03	Coloplast acquires Nine Continents Medical, Inc.	GL
11/03	COLOPLAST A/S : delivers solid full year results despite the COVID-19 pandemic a..	AQ
11/03	COLOPLAST A/S : - Announcement no. 10/2020 - Full-year Financial Results 2019/20	AQ
11/03	COLOPLAST A/S : Annual results	CO
10/29	COLOPLAST A/S : annual earnings release
09/30	COLOPLAST A/S : completes minority investment in Francis Medical	AQ

More news

News in other languages on COLOPLAST A/S

11/06	Les marchés s'en fichent, vraiment ?
11/06	AVIS D'ANALYSTES DU JOUR : ArcelorMittal, Casino, Crédit Agricole, Getinge, Lanx..
11/03	Rien ne va plus, les jeux ne sont pas encore faits
11/03	EN DIRECT DES MARCHES : BNP Paribas, EssilorLuxottica, Carrefour, Adecco, HelloF..
10/29	COLOPLAST A/S : publication des résultats annuels

More news

Provided by Scoopnest.com

Chart COLOPLAST A/S

Duration : Period :

Coloplast A/S Technical Analysis Chart | COLO B | DK0060448595 | MarketScreener

Full-screen chart

Technical analysis trends COLOPLAST A/S

	Short Term	Mid-Term	Long Term
Trends	Neutral	Bearish	Neutral

Technical analysis

Income Statement Evolution

More Financials

Consensus

Sell

Buy

Mean consensus	HOLD
Number of Analysts	19
Average target price	940,11 DKK
Last Close Price	911,60 DKK
Spread / Highest target	25,3%
Spread / Average Target	3,13%
Spread / Lowest Target	-17,2%

Consensus

EPS Revisions

More Estimates Revisions

Managers

Name	Title
Kristian Villumsen	President & Chief Executive Officer
Lars Søren Rasmussen	Chairman
Allan Rasmussen	Executive Vice President-Global Operations
Anders Lonning-Skovgaard	Chief Financial Officer & Executive Vice President
Oliver Johansen	Senior VP-Global Research & Development

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

COLOPLAST A/S	10.31%	31 361



TELEFLEX INCORPORATED	1.07%	17 717
TOP GLOVE CORPORATION BHD.	354.47%	13 390
HARTALEGA HOLDINGS	162.77%	12 185
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED	71.73%	9 124
SUPERMAX CORPORATION	1,209.35%	5 547

More Results